JPMorgan Chase & Co
ARTV

JPMorgan Chase & Co’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

JPMorgan Chase & Co’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.31K Sell
865
-17,018
-95% -$25.7K ﹤0.01% 5710
2025
Q1 		$53.6K Sell
17,883
-19,736
-52% -$59.2K ﹤0.01% 5012
2024
Q4 		$379K Buy
37,619
+26,893
+251% +$271K ﹤0.01% 4269
2024
Q3 		$166K Buy
+10,726
New +$166K ﹤0.01% 4538